REN and chronic kidney disease: A clinical trial, known as the Cilnidipine versus Amlodipine Randomized Trial for Evaluation in Renal Disease (CARTER), demonstrated that cilnidipine, when added to renin-angiotensin system inhibitors, significantly reduced proteinuria in hypertensive patients with chronic kidney disease compared to amlodipine [25].